Therapeutic Asset Ratings

6,299 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap Head And Neck Cancer	National Cancer Institute (NCI)	P1/2	CC (44)
Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap Sarcoma	National Cancer Institute (NCI)	P1/2	CC (44)
Infigratinib Grade II Glioma	Helsinn Healthcare SA	P1/2	CC (44)
Inkmune Metastatic Prostate Carcinoma	Inmune Bio, Inc.	P1/2	CC (44)
Inobrodib Acute Myeloid Leukemia	CellCentric Ltd.	P1/2	CC (44)
Inobrodib Hematopoietic And Lymphoid System Neoplasm	CellCentric Ltd.	P1/2	CC (44)
Ivuxolimab Metastatic Prostate Carcinoma	M.D. Anderson Cancer Center	P1/2	CC (44)
Ivuxolimab Refractory Malignant Neoplasm	M.D. Anderson Cancer Center	P1/2	CC (44)
Ivuxolimab Prostate Cancer	M.D. Anderson Cancer Center	P1/2	CC (44)
lb4330 Neoplasm	L & L Bio Co., Ltd., Ningbo, China	P1/2	CC (44)
Lenalidomide Monoclonal Gammopathy	Hellenic Society of Hematology	P1/2	CC (44)
Lenalidomide Primary Effusion Lymphoma	National Cancer Institute (NCI)	P1/2	CC (44)
Lenalidomide Triple-Negative Breast Carcinoma	Andrew Hantel, MD	P1/2	CC (44)
Lenvatinib Gastroesophageal Cancer	Salubris Biotherapeutics Inc	P1/2	CC (44)
LMP744 Glioblastoma	National Institute of Neurological Disorders and Stroke (NINDS)	P1/2	CC (44)
Lorlatinib Metastatic Neoplasm	Memorial Sloan Kettering Cancer Center	P1/2	CC (44)
L-Valine, S-L-Valyl-(3S,4E)-3-Hydroxy-7-Mercapto-4-Heptenonyl-2-(Aminomethyl)-4-Thiazolecarbonyl-2-Methylalanyl-, (5?2)-Lactone, Benzenesulfonate (1:1) Melanoma	OnKure, Inc.	P1/2	CC (44)
Mavrostobart Non-Small Cell Lung Carcinoma	Phanes Therapeutics	P1/2	CC (44)
Mezigdomide Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P1/2	CC (44)
Monoclonal Antibody Neo-201 Uterine Cancer	Precision Biologics, Inc	P1/2	CC (44)
Navlimetostat Non-Small Cell Lung Carcinoma	M.D. Anderson Cancer Center	P1/2	CC (44)
Nbt-Nm108 Multiple Sclerosis	Suhayl Dhib-Jalbut, MD	P1/2	CC (44)
Nelitolimod Hepatocellular Carcinoma	University of California, San Diego	P1/2	CC (44)
Olaparib Metastatic Malignant Neoplasm In The Brain	Colette Shen	P1/2	CC (44)
Olaparib Meningioma	Fundación de investigación HM	P1/2	CC (44)

Showing 4026 to 4050 of 6,299 assets

PreviousPage 162 of 252Next